State Board of Administration of Florida Retirement System’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-11,531
Closed -$173K 2396
2016
Q2
$173K Buy
11,531
+840
+8% +$10.8K ﹤0.01% 2242
2016
Q1
$130K Hold
10,691
﹤0.01% 2301
2015
Q4
$170K Buy
10,691
+41
+0.4% +$645 ﹤0.01% 2301
2015
Q3
$163K Buy
10,650
+120
+1% +$2.59K ﹤0.01% 2298
2015
Q2
$256K Buy
10,530
+181
+2% +$4.34K ﹤0.01% 2247
2015
Q1
$241K Buy
10,349
+130
+1% +$3.44K ﹤0.01% 2267
2014
Q4
$257K Hold
10,219
﹤0.01% 2279
2014
Q3
$318K Hold
10,219
﹤0.01% 2194
2014
Q2
$264K Buy
+10,219
New +$227K ﹤0.01% 2327

State Board of Administration of Florida Retirement System's SGNT Position: Q3 2016 in Review

State Board of Administration of Florida Retirement System sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 11,531 shares — an estimated $173K sold.

State Board of Administration of Florida Retirement System first reported a position in SGNT in Q2 2014 and held it in 9 quarters. The position peaked at $318K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • State Board of Administration of Florida Retirement System reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 11,531 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $173K.
  • State Board of Administration of Florida Retirement System first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 9 quarters.
  • State Board of Administration of Florida Retirement System's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $318K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q3 2016, filed 14 Nov 2016.